Literature DB >> 9248747

Viral replication in patients with concomitant hepatitis B and C virus infections.

J Crespo1, J L Lozano, B Carte, B de las Heras, F de la Cruz, F Pons-Romero.   

Abstract

The aim of this study was to assess the implications of dual infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). The HBV and HCV status in 100 patients with chronic hepatitis was analysed. HBV DNA was studied using liquid hybridization and the polymerase chain reaction (PCR). HCV viremia was measured using qualitative and quantitative PCR. The HCV genotype was determined by PCR. Patients were divided into three groups according to their HCV-RNA and HBsAg status: group I consisted of 40 patients with chronic hepatitis caused by HBV; group II, 40 patients with chronic hepatitis caused by HCV; and group III, 20 patients infected with both viruses. The HBV-DNA level was higher in group I than in group III (66.4 vs. 11.5 pg/ml; p < 0.05). Quantification of HCV viremia revealed mean values of 36.9 copies x 10(5)/ml in group II and 5.5 copies/ml x 10(5) in group III (p < 0.05). The mean aminotransferase level and histological activity were higher in group III. HCV genotype lb was the predominant type. The data suggest that there is reciprocal inhibition of viral replication in patients with dual HBV and HCV infection. Liver disease appears to be more severe in patients with chronic hepatitis B and C.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248747     DOI: 10.1007/bf02471908

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

1.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

2.  Mixed infections of hepatitis C virus as a factor in acute exacerbations of chronic type C hepatitis.

Authors:  J H Kao; P J Chen; M Y Lai; P M Yang; J C Sheu; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

3.  Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C.

Authors:  C M Chu; Y F Liaw
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

4.  Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: the role of hepatitis B, C or D?

Authors:  Z Ackerman; B Valinluck; J G McHutchison; A G Redeker; S Govindarajan
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

5.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

6.  Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation.

Authors:  C M Shih; C M Chen; S Y Chen; Y H Lee
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Hepatitis C viremia in patients with hepatitis C virus infection.

Authors:  A S Lok; R Cheung; R Chan; V Liu
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

8.  Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection.

Authors:  I S Sheen; Y F Liaw; C M Chu; C C Pao
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

9.  Chronic hepatitis in multiple virus infection: histopathological evaluation.

Authors:  R Colombari; A P Dhillon; E Piazzola; A A Tomezzoli; G P Angelini; F Capra; A Tomba; P J Scheuer
Journal:  Histopathology       Date:  1993-04       Impact factor: 5.087

10.  Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation.

Authors:  E J Huang; T L Wright; J R Lake; C Combs; L D Ferrell
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

View more
  9 in total

1.  Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study.

Authors:  Naser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Armin Rashidi; Iman Khodarahmi
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment.

Authors:  Ioannis-S Elefsiniotis; Elena Vezali; Konstantinos Kamposioras; Konstantinos-D Pantazis; Radostina Tontorova; Ioannis Ketikoglou; Antonios Moulakakis; George Saroglou
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

3.  Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.

Authors:  Chun-Lei Fan; Lai Wei; Dong Jiang; Hong-Song Chen; Yan Gao; Ruo-Bing Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: A review of the evidence and current recommendations.

Authors:  Jane A Buxton; Jin Hee Kim
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

5.  Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus.

Authors:  Fernando Lopes Gonçales; Josiane Silveira Felix Pereira; Claudia Da Silva; Glaucimari Roberto Thomaz; Maria Helena Postal Pavan; Viviane Cristina Fais; Luis Alberto Magna; Neiva Sellan Lopes Gonçales
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  Hepatitis C infection among drug users attending general practice.

Authors:  W Cullen; G Bury; J Barry; F D O'Kelly
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

7.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.

Authors:  Zhihua Liu; Jinlin Hou
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

8.  Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin.

Authors:  Janine Hartl; Claudia Ott; Gabriele Kirchner; Bernd Salzberger; Reiner Wiest
Journal:  Clin Pract       Date:  2012-07-10

9.  Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital.

Authors:  Habtie Tesfa; Belete Biadgo; Fasika Getachew; Kifle Tegegne; Gizachew Yismaw; Dagnachew Muluye
Journal:  BMC Res Notes       Date:  2013-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.